{"id":617545,"date":"2022-09-20T19:54:01","date_gmt":"2022-09-20T19:54:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=617545"},"modified":"2022-09-20T19:54:01","modified_gmt":"2022-09-20T19:54:01","slug":"automatic-sampling-systems-market-is-anticipated-to-grow-at-a-cagr-of-over-15-by-2035-roots-analysis","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/automatic-sampling-systems-market-is-anticipated-to-grow-at-a-cagr-of-over-15-by-2035-roots-analysis_617545.html","title":{"rendered":"Automatic Sampling Systems Market is anticipated to grow at a CAGR of over 15% by 2035 | Roots Analysis"},"content":{"rendered":"
Given the advanced features and cost saving potential, automatic sampling systems have been widely adopted by various stakeholders in biopharmaceutical industry, to monitor data in real-time and reduce deviations associated with manual sampling<\/div>\n

Roots Analysis<\/strong> has announced the addition of “Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA, 2022-2035<\/strong><\/a>” report to its list of offerings.  <\/p>\n

The automatic sampling systems have diverse applications, including bioprocess \/ analyte monitoring, data management and advanced process control \/ feedback control, in biotechnology and pharmaceutical industries. As a result, several bioprocess equipment developers have been engaged in the development of user-friendly, controlled, and automated systems to increase the productivity and flexibility of the bioprocess. <\/p>\n

Key Market Insights<\/strong><\/p>\n

Currently, more than 55 automatic sampling systems are available in the market<\/strong><\/p>\n

Majority (71%) of the automatic sampling systems are capable of on-line monitoring, followed by off-line (22%) and at-line monitoring (7%). It is worth noting that around 25% of the automatic sampling systems offer multiplexer module for withdrawing the sterile samples, followed by systems containing routing module (23%) that can transfer the sample to various analyzers.<\/p>\n

Around 45 companies are presently engaged in the manufacturing of automatic sampling systems, globally<\/strong><\/p>\n

The automatic sampling industry is dominated by the presence of mid-sized players (51-200 employees), representing more than 40% of the total automatic sampling system manufacturers<\/strong>. Further, about 15% firms were established post-2010. In addition, majority (54%) of the players engaged in this domain are based in Europe, followed by North America (32%).<\/p>\n

Close to 20 automatic sample collection \/ preparation systems are presently available<\/strong><\/p>\n

Majority of the automatic sample collection \/ preparation systems (84%) are stand-alone systems. This is followed by integrated systems which capture 16% share in this domain. Further, most of these systems (nearly 40%) are being used in the pharmaceutical industry, followed by the biotechnology industry (35%).<\/p>\n

Over 400 patents related to automatic sampling in biopharmaceutical industry have been filed \/ granted, since 2016<\/strong><\/p>\n

Owing to the increase in research and development efforts led by several industry and non-industry players engaged in this domain, close to 50% of patent applications have been filed post-2016. It is worth noting that 56% patents related to automatic sampling systems were filed \/ granted in the US alone.<\/p>\n

Partnership activity in this field has increased at a CAGR of nearly 30%, between 2017 and 2021<\/strong><\/p>\n

Around 45% of the deals were inked in 2020 and 2021. Majority of the instances captured in the report (~40%) were product distribution agreements. Further, most of the agreements were inked with players based in North America (nearly 70%).<\/p>\n

Over 25 global events related to automatic sampling systems were organized in the past couple of years<\/strong><\/p>\n

Majority (~80%) of the events related to automatic sampling systems, were organized virtually in order to comply with the guidelines in the ongoing COVID-19 pandemic. It is worth highlighting that the agendas of the events organized post-2020 include discussions on the potential, advancements and challenges associated with these systems in various bioprocessing operations.<\/p>\n

North America is anticipated to capture over 50% of the global market share for automatic sampling systems, by 2035<\/strong><\/p>\n

The market will be primarily driven by sales of automatic sampling systems capable of on-line monitoring (59%). Further, systems which are used in upstream bioprocessing method are expected to occupy a larger share (60%) of the overall market (in terms of sales-based revenues), by 2035.<\/p>\n

Key Questions Answered<\/strong><\/p>\n